Dr. Eric D. Anderson

David Duhamel is an Intensive Care Medicine specialist and a Pulmonary Medicine provider in Falls Church, Virginia. Dr. Duhamel is rated as a Distinguished provider by MediFind in the treatment of EGFR Positive Lung Cancer. His top areas of expertise are Small Cell Lung Cancer (SCLC), Squamous Cell Lung Carcinoma, Lung Adenocarcinoma, ALK-Positive Non-Small Cell Lung Cancer, and Gastrostomy. Dr. Duhamel is currently accepting new patients.

Rebecca Krochmal is a Pulmonary Medicine specialist and an Intensive Care Medicine provider in Washington, Washington, D.c.. Dr. Krochmal has been practicing medicine for over 17 years and is rated as a Distinguished provider by MediFind in the treatment of EGFR Positive Lung Cancer. Her top areas of expertise are Lung Cancer, Squamous Cell Lung Carcinoma, Lung Adenocarcinoma, Endoscopy, and Gastrostomy. Dr. Krochmal is currently accepting new patients.

Peter G. Hamm, M.D., is a pulmonologist with Johns Hopkins Medicine Pulmonology. Dr. Hamm is also the chairman of the department of medicine and the chairman of the intensive care unit (ICU) committee at Sibley Memorial Hospital. Dr. has an expertise in annual physicals, acute and urgent care, disease management and pulmonary medicine. He earned his medical degree from Columbia University College of Physicians and Surgeons. He went on to complete his residency in internal medicine at St. Luke’s Hospital, followed by a fellowship in pulmonary medicine at Bellevue Hospital Center. Dr. Hamm has been named a Top Doctor in the Washington, D.C., Baltimore and Washington-Baltimore areas by Castle Connolly. He has also been named a Top MD by Consumers’ Checkbook Magazine. Dr. Hamm contributed to a publication on the diagnosis of pulmonary Kaposi’s sarcoma with fiberoptic bronchoscopy and endobronchial biopsy. Dr. Hamm is rated as an Advanced provider by MediFind in the treatment of EGFR Positive Lung Cancer. His top areas of expertise are ALK-Positive Non-Small Cell Lung Cancer, Large-Cell Lung Carcinoma, Squamous Cell Lung Carcinoma, and Lung Adenocarcinoma.